Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells

Autor: Thérèse Astier-Gin, Julie Rumi, Laura Tarrago-Litvak, Michel Ventura, Marie-Line Andreola, Christian Cazenave, Pantxika Bellecave, Ophélie Cosnefroy, Cathy Staedel
Přispěvatelé: Microbiologie cellulaire et moléculaire et pathogénicité (MCMP), Université Bordeaux Segalen - Bordeaux 2-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2008
Předmět:
MESH: SELEX Aptamer Technique
MESH: Aptamers
Nucleotide

Hepacivirus
Viral Nonstructural Proteins
Virus Replication
medicine.disease_cause
chemistry.chemical_compound
RNA polymerase
Pharmacology (medical)
MESH: Hepacivirus
Polymerase
0303 health sciences
biology
SELEX Aptamer Technique
030302 biochemistry & molecular biology
virus diseases
Aptamers
Nucleotide

3. Good health
Infectious Diseases
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
MESH: RNA
Viral

RNA
Viral

MESH: Virion
MESH: RNA Replicase
MESH: Cell Line
Tumor

Hepatitis C virus
Aptamer
RNA-dependent RNA polymerase
Transfection
Antiviral Agents
Cell Line
03 medical and health sciences
Cell Line
Tumor

medicine
Humans
NS5B
030304 developmental biology
Pharmacology
MESH: Humans
MESH: Transfection
MESH: Virus Replication
Virion
RNA
RNA-Dependent RNA Polymerase
Virology
Molecular biology
digestive system diseases
MESH: Cell Line
chemistry
biology.protein
MESH: Viral Nonstructural Proteins
Zdroj: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2008, 52 (6), pp.2097-110. ⟨10.1128/AAC.01227-07⟩
ISSN: 0066-4804
1098-6596
DOI: 10.1128/AAC.01227-07⟩
Popis: We describe here the further characterization of two DNA aptamers that specifically bind to hepatitis C virus (HCV) RNA polymerase (NS5B) and inhibit its polymerase activity in vitro. Although they were obtained from the same selection procedure and contain an 11-nucleotide consensus sequence, our results indicate that aptamers 27v and 127v use different mechanisms to inhibit HCV polymerase. While aptamer 27v was able to compete with the RNA template for binding to the enzyme and blocked both the initiation and the elongation of RNA synthesis, aptamer 127v competed poorly and exclusively inhibited initiation and postinitiation events. These results illustrate the power of the selective evolution of ligands by exponential enrichment in vitro selection procedure approach to select specific short DNA aptamers able to inhibit HCV NS5B by different mechanisms. We also determined that, in addition to an in vitro inhibitory effect on RNA synthesis, aptamer 27v was able to interfere with the multiplication of HCV JFH1 in Huh7 cells. The efficient cellular entry of these short DNAs and the inhibitory effect observed on human cells infected with HCV indicate that aptamers are useful tools for the study of HCV RNA synthesis, and their use should become a very attractive and alternative approach to therapy for HCV infection.
Databáze: OpenAIRE